Page 1 of Clinical Trials for Vascular Biogenics Ltd. operating as VBL Therapeutics [SPONSOR-COLLABORATORS], 5 Total Matches
- 1RecruitingSingle-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma MultiformeLast Updated: November 15, 2011Condition(s): Relapsed Glioblastoma Multiforme
- 2RecruitingLast Updated: March 11, 2012Condition(s): Advanced and/or Metastatic Solid Organ Cancer
- 3CompletedLast Updated: November 15, 2011Condition(s): Biomarker
- 4Active, not recruitingLast Updated: November 15, 2011Condition(s): Differential Thyroid Cancer
- 5CompletedLast Updated: November 15, 2011Condition(s): Active Plaque Psoriasis
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Vascular+Biogenics+Ltd.+operating+as+VBL+Therapeutics
